MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$21,085K
Net loss
-$21,085K
Interest income
$1,239K
Loss from operations
-$22,288K
Interest expense
$32K
Other expense, net
-$4K
Total operating
expenses
$22,288K
General and
administrative
$11,328K
Research and development
$10,960K
Back
Back
Income Statement
source: myfinsight.com
Sensei Biotherapeutics, Inc. (SNSE)
Sensei Biotherapeutics, Inc. (SNSE)